| Wu, Yun |
State University Of New York At Buffalo
United States |
Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay |
5R01CA272827-02 |
Guillermo Marquez, Ph.D. |
| Osarogiagbon, Raymond U |
Baptist Memorial Hospital - Tipton
United States |
Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium |
5UG1CA189873-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis |
1U01CA288375-01 |
|
| Schallenkamp, John M. |
Montana Cancer Consortium
United States |
Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming |
5UG1CA189872-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
High-throughput immunoproteomics for cancer biomarker discovery |
5U2CCA271903-02 |
Christos Patriotis, Ph.D., M.Sc. |
| Anderson, Daniel M |
Healthpartners Institute
United States |
Metro-Minnesota Community Oncology Research Consortium (MMCORC) |
5UG1CA189863-11 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Santos-Reyes, Luis Javier |
Comprehensive Cancer Center/ Univ/Pr
United States |
Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP) |
5UG1CA189862-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Suga, Jennifer Marie |
Kaiser Foundation Research Institute
United States |
Kaiser Permanente NCI National Community Oncology Research Program, NCORP |
5UG1CA189821-10 |
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Anderson, Garnet L. |
Fred Hutchinson Cancer Center
United States |
NCI Cancer Screening Research Network: Coordinating and Communication Center |
1UG1CA286954-01 |
Elyse LeeVan, M.D., M.P.H. |
| Hinds, Pamela S |
Children'S Research Institute
United States |
Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment |
5R01CA212190-05 |
|